Price
No data yet.
Social Signal Score
Revenue
$1.63B+185.19%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Britt Meelby Jensen
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 5,384
- Beta
- 1.30
- Country
- DK
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 9.68
Financials
Revenue
$1.63B+185.2%Net Income
$155.44M+69.0%EBITDA
$319.86M+110.4%Free Cash Flow
$254.09M+221.6%EPS (diluted)
$0.58+52.6%Shares Outstanding (diluted)
266.56M+11.2%Operating Expenses
$751.32MCash & Debt
$702.49MReturn of Capital
$123.56MDividend per Share
$0.06Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $6.03B | $607.84M | $2.28 |
| 2024 | $5.39B | $235.00M | $0.88 |
| 2023 | $4.78B | $168.00M | $0.64 |
| 2022 | $4.44B | $93.00M | $0.37 |
| 2021 | $4.01B | $247.00M | $0.98 |
| 2020 | $3.57B | $241.00M | $0.98 |
| 2019 | $2.82B | $317.00M | $1.30 |
| 2018 | $2.61B | $337.00M | $1.39 |
| 2017 | $2.35B | $301.00M | $1.27 |
| 2016 | $2.08B | $250.00M | $1.05 |
| 2015 | $1.89B | $152.00M | $0.63 |
| 2014 | $1.58B | $151.00M | $0.64 |
| 2013 | $1.38B | $48.00M | $0.20 |
| 2012 | $1.05B | $110.00M | $0.47 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from AMBFF's reported EPS growth of 12.9% a year over 13 years.
- EPS in 5 years
- $4.18
- Implied price
- $179.92
- Return from $12.72
- 69.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $89.45 — today's price is already 85.8% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 31 | 37 | 43 | 49 | 55 |
|---|---|---|---|---|---|
| 2.9% | 45.0% | 50.2% | 54.8% | 58.9% | 62.6% |
| 7.9% | 52.1% | 57.5% | 62.3% | 66.6% | 70.5% |
| 12.9% | 59.1% | 64.8% | 69.9% | 74.4% | 78.4% |
| 17.9% | 66.2% | 72.1% | 77.4% | 82.1% | 86.3% |
| 22.9% | 73.2% | 79.4% | 84.9% | 89.8% | 94.2% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
120Social Signal Score
Mentions (1)
- Newsseekingalpha.com·5h ago·Positive
Ambu A/S (AMBBY) Q3 2026 Earnings Call Transcript Ambu A/S (AMBBY) Q3 2026 Earnings Call Transcript
View source ↗
Earnings
Thu, Nov 5(in 2 months)
Consensus estimate $0.11 per share
Typical surprise -8.2% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 26$0.09 vs $0.09miss
- Wed, May 6$0.07 vs $0.08miss
- Wed, Feb 4$0.07 vs $0.08miss
- Wed, Nov 5$0.07 vs $0.08miss
- Fri, Aug 22$0.07 vs $0.09miss
- Wed, May 7$0.10 vs $0.11miss
Estimates and results for AMBFF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.